Generic Name and Formulations:
Ceftaroline fosamil 400mg, 600mg; per vial; pwd for IV infusion after reconstitution and dilution.
Indications for TEFLARO:
Susceptible bacterial community-acquired pneumonia and acute skin and skin structure infections.
≥18yrs: Give by IV infusion over 5–60mins. Treat skin and skin structure for 5–14 days; treat pneumonia for 5–7days. CrCl >50mL/min: 600mg every 12hrs. Renal impairment (CrCl >30–≤50mL/min): 400mg every 12hrs; (CrCl ≥15–≤30mL/min): 300mg every 12hrs; ESRD (including hemodialysis): 200mg every 12hrs (dose after dialysis on dialysis days).
<2mos: not established. Give by IV infusion over 5–60mins. 2mos–<2yrs: 8mg/kg every 8hrs. ≥2yrs–<18yrs (≤33kg): 12mg/kg every 8hrs; (>33kg): 400mg every 8hrs or 600mg every 12hrs. All: treat for 5–14 days.
Penicillin or other beta-lactam allergy. GI disease (esp. colitis). Monitor for hemolytic anemia. Pregnancy. Nursing mothers.
May cause false (+) direct Coomb's test.
Diarrhea, nausea, vomiting, pyrexia, rash; pseudomembranous colitis, superinfection.
Endocrinology Advisor Articles
- Trends in Cardiovascular Deaths for US Adults With and Without Diabetes
- Diabetic Retinopathy Risk Not Increased With GLP-1 Receptor Agonist Use in T2D
- Concurrent Risk Factors and Microvascular Complications in Type 1 Diabetes
- Comparing Efficacies of Second-Line Treatments in Type 2 Diabetes
- Higher Risk for Meningioma Linked to GH Treatment, Radiotherapy During Childhood
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Hypertension Treatments: ARBs
- Semaglutide vs Liraglutide for Weight Loss in Patients With Obesity
- Liraglutide May Lower Risk for Foot Amputation in Type 2 Diabetes
- Thyroid Hormone Levels, Body Composition, Insulin Resistance in Euthyroid Patients
- Behavioral Weight Loss Interventions May Prevent Obesity
- Disaster Preparedness 101: Physician Resources for Patients
- Assessing the Environmental Impact of the Healthcare Industry
- Medical Schools Phase Out Lectures as Education Shifts Outside the Classroom
- Clonidine Testing Is Safe and Reliable for Diagnosing Growth Hormone Deficiency